Fact CheckerSign in

NCT04920539CompletedPhase 1

In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

In this study, the investigators hypothesize that THC alters the immunogenome in a cell type-specific fashion and alters cytokine production via epigenetic regulatory mechanisms and that these alterations differ between HIV-infected and HIV-uninfected host genomes.

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
56 (actual)
First submitted
17 May 2021
Start date
8 Feb 2022
Primary completion date
1 Dec 2025
Lead sponsor
Yale University
Diseases
HIV
NCT number
NCT04920539

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 56
  • From 8 Feb 2022 to the primary completion date, 1 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Major medical conditions, e.g., myocardial infarction, hypertension, etc.

Other

  • Positive pregnancy test and lactation;
  • Weight greater than 166 kg (365 lbs)

Who the study is looking for

  • HIV-positive
  • Good medication adherence
  • Negative urine toxicology for drugs of abuse (including cannabis)
  • Good mental and physical health (other than HIV) as determined by history, psychiatric interview, collateral information, physical and laboratory examinations, ECG, and vital signs.
  • HIV-negative
  • Negative urine toxicology for drugs of abuse (including cannabis)
  • Good mental and physical health as determined by history, psychiatric interview, collateral information, physical and laboratory examinations, ECG, and vital signs.

Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
VA Connecticut Healthcare System
Coordinator of this site? Confirm its status
West HavenUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.